SPY—
QQQ—
DIA—
NVDA—
AAPL—
TSLA—
MSFT—
BTC-USD—
15-min delayed
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

Alpha Tau Medical Ltd. Ordinary Shares

DRTS XNAS
$11.76 +0.77 (+6.81%) ▲ 15-min delayed
Open
$11.47
High
$12.19
Low
$11.31
Volume
628.9K
Market Cap
$1.09B

About Alpha Tau Medical Ltd. Ordinary Shares

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

Employees: 121 Website →

Related Market News

No specific coverage for DRTS yet. Check out our latest market news or earnings calendar.

Get DRTS Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Alpha Tau Medical Ltd. Ordinary Shares.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.